Safety Assessment of High- and Low-Molecular-Weight Hyaluronans (Profhilo®) as Derived from Worldwide Postmarketing Data.

Daniel CassutoMara DelledonneGiovanna ZaccariaImmacolata IllianoAndrea Maria GioriGilberto Bellia

Published in: BioMed research international (2020)

Although underreporting of minor events cannot be ruled out, the overall number of reports is very low, thereby supporting the high tolerability and safety of the product. After 3 years of postmarketing experience, the safety profile of the studied medical device is favorable and consistent with the product information.

Keyphrases

open label
emergency department
drug administration
big data
health information
machine learning
artificial intelligence
adverse drug
deep learning
solid state